Which of the following does not represent a significant anaesthetic problem in the morbidly obese patient?
**Core Concept**
The morbidly obese patient presents unique challenges in anesthesia due to altered physiology and pharmacokinetics, including changes in respiratory and cardiovascular function, altered distribution of body fat, and altered metabolism of anesthetic agents.
**Why the Correct Answer is Right**
In morbidly obese patients, airway management is often challenging due to macroglossia and a higher risk of aspiration. Additionally, obesity is associated with a higher risk of respiratory and cardiac complications, including obstructive sleep apnea, hypoxemia, and increased intra-abdominal pressure. Furthermore, obese patients may have altered pharmacokinetics of anesthetic agents, including increased volume of distribution and clearance, which can affect the duration and intensity of anesthesia.
**Why Each Wrong Option is Incorrect**
**Option A:** This is incorrect because obesity is associated with a higher risk of aspiration due to gastroesophageal reflux disease (GERD) and decreased lower esophageal sphincter pressure. Morbidly obese patients also have a higher risk of respiratory complications, including obstructive sleep apnea and hypoventilation.
**Option B:** This is incorrect because obesity is associated with a higher risk of cardiac complications, including hypertension, hyperlipidemia, and coronary artery disease, which can increase the risk of perioperative cardiac events.
**Option C:** This is incorrect because obesity is associated with a higher risk of wound complications, including infection and delayed healing, due to altered immune function and increased tissue tension.
**Clinical Pearl / High-Yield Fact**
Obese patients often require larger doses of anesthetic agents due to their increased volume of distribution, but may also have a higher risk of respiratory and cardiac complications.
**Correct Answer:** D.